Building a Strategic Commercialization Plan for Rare Disease Therapies 

Gain invaluable insights into pharmaceutical commercialization with the recording of the Access USA 2025 panel session: Manufacturer Considerations for Building a Strategic Commercialization Plan. Moderated by Stuart Kamin, this discussion brings together a panel of industry leaders sharing practical strategies to craft impactful commercialization plans.

The panel includes Justin Bush from Pharavis, Richard Wilson of Kyowa Kirin, Inc., and Carina Kaiser from Chiesi USA, Inc., who together tackle some of the most pressing challenges in today’s pharmaceutical market. From leveraging real-world data to overcoming market access hurdles, you’ll walk away with actionable strategies to drive your organization’s commercialization success.

Submit the form on this page to access the full panel session recording and gain valuable takeaways to strengthen your strategic approach.